Cargando…
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial
SIMPLE SUMMARY: Due to recent advances in breast cancer detection and treatment strategies, the number of breast cancer survivors has increased over the past decades. However, breast cancer follow-up guidelines have not changed for years. The presence of CTCs detected during follow-up has been shown...
Autores principales: | Trapp, Elisabeth K., Fasching, Peter A., Fehm, Tanja, Schneeweiss, Andreas, Mueller, Volkmar, Harbeck, Nadia, Lorenz, Ralf, Schumacher, Claudia, Heinrich, Georg, Schochter, Fabienne, de Gregorio, Amelie, Tzschaschel, Marie, Rack, Brigitte, Janni, Wolfgang, Friedl, Thomas W. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406108/ https://www.ncbi.nlm.nih.gov/pubmed/36010945 http://dx.doi.org/10.3390/cancers14163949 |
Ejemplares similares
-
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017) -
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2018) -
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
por: Schochter, Fabienne, et al.
Publicado: (2020) -
Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
por: Schochter, Fabienne, et al.
Publicado: (2019) -
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial
por: de Gregorio, Amelie, et al.
Publicado: (2020)